Table 1.
Summary of the patient baseline characteristics from men undergoing a radical prostatectomy.
| Characteristics | Total | Range |
|---|---|---|
| Age, years | 62 ± 8 (60) | 42–78 |
| PSA, µg/L | 6.88 ± 5.50 (58) | 1.4–30 |
| BMI, kg/m2 | 26.9 ± 3.4 (57) | 21.3–35.6 |
| Waist Circumference, cm | 95.8 ± 8.8 (50) | 81–117 |
| Gleason Score | ||
| ≤3 + 3 | 3 | |
| 3 + 4 | 29 | |
| 4 + 3 | 13 | |
| ≥4 + 4 | 15 | |
| Pathological T Stage | ||
| T2 | 29 | |
| T3a | 27 | |
| T3b | 4 | |
| T4 | 0 | |
| Blood Serum, n | 60 | |
| Glucose, mmol/L | 5.3 ± 0.7 | 3.6–7.1 |
| Insulin, pmol/L | 31 ± 23 | 7–136 |
| Cholesterol, mmol/L | 4.5 ± 1.0 | 2.4–6.2 |
| Triacylglycerol, mmol/L | 1.2 ± 0.4 | 0.5–2.4 |
| HDL, mmol/L | 1.3 ± 0.4 | 0.76–2.63 |
| LDL, mmol/L | 2.6 ± 1.0 | 0.3–5.2 |
Data are mean ± SD (n), except for Gleason score and pathological T stage, which is the number of cases.